Akermin raises $5M for fuel-cell bioenzymes
NOTE: This item also appears in Monday’s daily briefing at VentureBeat Life Sciences.
Akermin, a St. Louis developer of new biocatalytic enzymes, raised $5 million in a second tranche of its first funding round. Investors included Prolog Ventures, OnPoint Technologies, Chrysalix Energy and the St. Louis Arch Angels.
Akermin works with catalytic enzymes — molecules that speed particular chemical reactions — developed with biotechnology that could replace precious-metal catalysts now used in fuel cells. The company is developing… Continue Reading